Tribenzor Approval History
- FDA approved: Yes (First approved July 23rd, 2010)
- Brand name: Tribenzor
- Generic name: amlodipine, hydrochlorothiazide and olmesartan
- Dosage form: Tablets
- Company: Daiichi Sankyo
- Treatment for: High Blood Pressure
Tribenzor (amlodipine, hydrochlorothiazide and olmesartan) is a three-in-one combination product taken once-daily for the treatment of hypertension.
Development History and FDA Approval Process for Tribenzor
|Jul 26, 2010||FDA Approves Tribenzor, A New Three-In-One Combination Product for the Treatment of High Blood Pressure|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.